Targeted News Service logo

-- Preview Email Newsletter
Federal Tipoffs Involving Massachusetts Newsletter for 2024-12-19 ( 3 items )  
Department of Labor Secures Consent Judgment Prohibiting Massachusetts Contractor From Retaliating Against Employees (10)
WASHINGTON, Dec. 19 -- The U.S. Department of Labor Wage and Hour Division issued the following news brief on Dec. 17, 2024: * * * Evolution Group, owners must also pay $35K in punitive damages * * * Date of action: Nov. 22, 2024 Type of action: Consent judgment and order Employers: Evolution Group Inc., Junior Moreira de Lima, Vitor Moreira 147 Congress St., Milford, Massachusetts 01757 Allegations: The U.S. Department of Labor filed suit on March 7, 2024, alleging the construction cont more PR

Justice Dept.: Founder of Iranian Company Arrested for Providing Material Support to Islamic Revolutionary Guard Corps, for Scheme to Procure Sensitive U.S. Technology for Use in IRGC Military Drones, (10)
WASHINGTON, Dec. 16 -- The U.S. Department of Justice issued the following news release: * * * Founder of Iranian Company and his Co-Defendant, an Employee of a U.S. Microelectronics Manufacturer, Also Charged with Violating Export Control Laws in Conspiracy to Procure Sensitive U.S. Technology for Use in IRGC Military Drones * * * Mahdi Mohammad Sadeghi, 42, a dual U.S.-Iranian national of Natick, Massachusetts, and Mohammad Abedininajafabadi, also known as Mohammad Abedini (Abedini), 38, o more PR

Litigation: SEC Charges Principal Investigator of Pharmaceutical Trial With Insider Trading (10)
WASHINGTON, Dec. 19 -- The Securities and Exchange Commission issued the following litigation release (No. 1:24-cv-13113; D. Mass. filed Dec. 18, 2024) involving Sai-Hong Ignatius Ou: * * * The Securities and Exchange Commission today filed charges against Sai-Hong Ignatius Ou, a physician and clinical professor at a California public university, for insider trading in advance of an October 28, 2022, public announcement relaying positive news about clinical trials of a cancer fighting drug bei more PR